References

Outcomes of germline testing for children with hematologic malignancies undergoing hematopoietic cell transplantation

2026 · External reference

Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes

10.3324/haematol.2019.237693 · 2021 · External reference

The clinical and functional effects of TERT variants in myelodysplastic syndrome

10.1182/blood.2021011075 · 2021 · External reference

Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT)

10.1111/bjh.18682 · 2023 · External reference

Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT

10.1016/s2352-3026(23)00265-x · 2023 · External reference

Donor-derived malignancy and transplantation morbidity: risks of patient and donor genetics in allogeneic hematopoietic stem cell transplantation

2024 · External reference

Germline predispositions to myeloid malignancies: across the lifespan

10.1053/j.seminhematol.2025.08.002 · 2025 · External reference

Insights into germline predisposition to pediatric lymphoid malignancies

10.1038/s41375-025-02750-z · 2025 · External reference

Risk of cancer in heterozygous relatives of patients with Fanconi anemia

10.1016/j.gim.2021.08.013 · 2022 · External reference

Genome-first determination of the prevalence and penetrance of eight germline myeloid malignancy predisposition genes: a study of two population-based cohorts

10.1038/s41375-024-02436-y · 2025 · External reference